A new financial disclosure filed with the U.S. House of Representatives shows that Rep. Julia Letlow sold shares of CVS Health Corp [CS] on December 11, 2024. The transaction was made personally by the member of Congress, not by a spouse or dependent, and falls into the disclosed value range of $1,001 to $15,000.
The stock was held through a Merrill Lynch Investment Account, identified in the filing as Account #025. Notably, Letlow’s own filing describes the underlying asset as a ‘Corporate Bond,’ even though the transaction is listed against CVS Health Corp’s stock ticker [CS]. Periodic Transaction Reports sometimes include filer-supplied descriptions that differ from the asset type implied by the ticker itself, and this report is no exception. We are presenting the filer’s description exactly as submitted, without attempting to reconcile the discrepancy.
A Reporting Delay Beyond the 45-Day Window
Under the STOCK Act, members of Congress are required to disclose covered securities transactions within 45 days of becoming aware of them. In this case, the sale occurred on December 11, 2024, but the disclosure was not filed until 243 days later, well outside that statutory window. We are noting this gap factually, as part of the public record, without speculating about why the filing was delayed.
Our internal classification system logs this event simply as a ‘congress sale,’ reflecting the transaction type and the fact that it was executed by the member herself rather than a family member. This classification is used purely for tracking and pattern purposes across the disclosures we monitor and does not represent an assessment of intent, timing strategy, or investment merit.
STOCK Act disclosures like this one are a legal requirement for members of Congress, designed to create transparency around potential conflicts of interest between personal financial holdings and legislative or oversight responsibilities. Filing a Periodic Transaction Report, even one submitted after the 45-day deadline, is a routine part of compliance with that law rather than an indication of wrongdoing. Late filings occur periodically across both parties and chambers of Congress, and the STOCK Act itself does not equate a delay with any violation beyond the reporting requirement.
Readers interested in tracking congressional trading activity can view this filing as one data point among many that whoisbuyingnow.com monitors as part of its ongoing coverage of disclosures made under the STOCK Act. As always, this reporting is intended to inform the public about disclosed transactions, not to suggest any course of action regarding CVS Health Corp or any other security mentioned.